Matterhorn Capital Management’s Gilead Sciences GILD Stock Holding History

Matterhorn Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.04M	Sell	13,179 -3,380	-20%	-$275K	0.69%	37
2016 Q2	$1.38M	Sell	16,559 -2,049	-11%	-$182K	0.88%	32
2016 Q1	$1.71M	Sell	18,608 -19,130	-51%	-$1.73M	1.11%	44
2015 Q4	$3.82M	Buy	37,738 +4,974	+15%	+$518K	1.74%	29
2015 Q3	$3.22M	Sell	32,764 -231	-0.7%	-$25.7K	1.55%	32
2015 Q2	$3.86M	Sell	32,995 -1,157	-3%	-$126K	1.65%	23
2015 Q1	$3.35M	Sell	34,152 -4,502	-12%	-$457K	1.5%	38
2014 Q4	$3.64M	Sell	38,654 -1,600	-4%	-$165K	1.71%	27
2014 Q3	$4.29M	Sell	40,254 -1,900	-5%	-$186K	1.92%	19
2014 Q2	$3.5M	Buy	+42,154	New	+$3.28M	1.55%	26

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Matterhorn Capital Management's GILD Position: Q3 2016 in Review

Matterhorn Capital Management reduced its Gilead Sciences (GILD) stake by 20% in Q3 2016, selling an estimated $275K and leaving 13,179 shares worth $1.04M. The position accounts for 0.69% of the portfolio, ranked #37.

Matterhorn Capital Management first reported a position in GILD in Q2 2014 and has held it in 10 quarters since. The position peaked at $4.29M in Q3 2014. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Matterhorn Capital Management held 13,179 shares of Gilead Sciences worth $1.04M as of Q3 2016.
Matterhorn Capital Management sold 3,380 Gilead Sciences shares in Q3 2016, an estimated $275K.
Gilead Sciences made up 0.69% of Matterhorn Capital Management's portfolio in Q3 2016, its #37 holding.
Matterhorn Capital Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 10 quarters since.
Matterhorn Capital Management's Gilead Sciences position peaked at $4.29M in Q3 2014.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Matterhorn Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.